![](/images/graphics-bg.png)
Antiphospholipid antibodies in patients with type 2 diabetes mellitus
العناوين الأخرى
الأجسام المضادة للشحوم الفوسفاتية لدى مرضى السكري من النوع الثاني
المؤلفون المشاركون
Husayn, Ahmad Muayyad
Hasu, Nada Abd Allah
Fadil, Ali Salah
المصدر
Annals of the College of Medicine Mosul
العدد
المجلد 41، العدد 2 (30 يونيو/حزيران 2019)، ص ص. 106-111، 6ص.
الناشر
تاريخ النشر
2019-06-30
دولة النشر
العراق
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
Patients with diabetes mellitus type 2 have a greater risk of accelerated atherosclerosis.
Antiphospholipid antibodies(aPL)are associated with greater risk for thrombosis.
To demonstrate the possible role of anticardiolipin(aCL) and anti-β2 glycoprotein(β2 GP1) antibodies in such patients, we investigate the presence of these antibodies in a group of type 2 diabetic patients.
Objectives: 1.
To investigate the presence of anticardiolipin IgM and IgG antibodies and anti-β2 GP1 IgG antibodies in diabetic patients and compare them with a control group.
2.
To analyze their potential implication in the occurrence of vasculopathy in such patients.
Patients and Methods: Fifty patients with type 2 diabetes mellitus and 33 healthy subjects were included in the study.
Each blood sample was tested for IgM, IgG aCL antibodies and for anti-β2 GP1 IgG antibodies.
Results: Seven patients were positive for aCL IgM, 6 were positive for aCL IgG and 4 patients were positive for anti-β2 GP1 IgG antibodies.
There was no differences in the means of IgM, IgG aCL and anti-β2 GP1 IgG antibodies titers in patients with complicated and uncomplicated diabetes mellitus.
Conclusion: The aCL and β2 GP1 antibodies positive titer means among type2 diabetics were significantly higher than non-diabetic subjects.
Positive but low titers of aCL and β2 GPI antibodies could suggest that these autoantibodies may play a minor role in the pathogenesis of atherosclerosis.
Low titers of aCL and β2 GPI antibodies were seen in complicated and non-complicated diabetic populations that probably lessen the importance of these autoantibodies as effective contributors in the pathogenesis of diabetic vasculopathy.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Hasu, Nada Abd Allah& Husayn, Ahmad Muayyad& Fadil, Ali Salah. 2019. Antiphospholipid antibodies in patients with type 2 diabetes mellitus. Annals of the College of Medicine Mosul،Vol. 41, no. 2, pp.106-111.
https://search.emarefa.net/detail/BIM-946588
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Hasu, Nada Abd Allah…[et al.]. Antiphospholipid antibodies in patients with type 2 diabetes mellitus. Annals of the College of Medicine Mosul Vol. 41, no. 2 (Jun. 2019), pp.106-111.
https://search.emarefa.net/detail/BIM-946588
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Hasu, Nada Abd Allah& Husayn, Ahmad Muayyad& Fadil, Ali Salah. Antiphospholipid antibodies in patients with type 2 diabetes mellitus. Annals of the College of Medicine Mosul. 2019. Vol. 41, no. 2, pp.106-111.
https://search.emarefa.net/detail/BIM-946588
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 110-111
رقم السجل
BIM-946588
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)